Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

8.690 -0.330 (-3.66%)
Streaming Delayed Price Updated: 3:27 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Evolent Health (NYSE:EVH)
Let’s dig into the relative performance of Evolent Health (NYSE:EVH) and its peers as we unravel the now-completed Q2 healthcare technology for providers earnings season. 
Via StockStory
Topics Artificial Intelligence
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy
The Analyst Verdict: Evolent Health In The Eyes Of 4 Experts
 
Via Benzinga
Why Elevance Health (ELV) Stock Is Trading Lower Today
Shares of health insurance provider Elevance Health (NYSE:EVH) fell 3.5% in the afternoon session after the company's CFO flagged potentially elevated medical costs and weakening margins at an investor... 
Via StockStory
Earnings Scheduled For August 7, 2025
 
Via Benzinga
3 Low-Volatility Stocks That Concern Us
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
FTAI Infrastructure, Acadia Healthcare, agilon health, Clover Health, and Evolent Health Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy World Trade
3 Unprofitable Stocks with Open Questions
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
Lennox, Sportsman's Warehouse, CAVA, TreeHouse Foods, and Evolent Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S.... 
Via StockStory
Topics Economy Stocks
Brookdale, Evolent Health, Fortrea, 10x Genomics, and Organon Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Artificial Intelligence Economy
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. 
Via StockStory
Topics Bonds Economy Stocks
EVH Q2 Deep Dive: Revenue Falls Short, Guidance Cut as Margin Initiatives Continue
Healthcare solutions company Evolent Health (NYSE:EVH) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 31.3% year on year to $444.3 million. Next quarter’s revenue guidance... 
Via StockStory
3 Stocks Under $10 We Approach with Caution
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as... 
Via StockStory
Why Evolent Health (EVH) Stock Is Nosediving
Shares of healthcare solutions company Evolent Health (NYSE:EVH) fell 13.9% in the morning session after the company reported disappointing second-quarter 2025 financial results, missing analyst... 
Via StockStory
Topics Stocks World Trade
Evolent Health (NYSE:EVH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops
Healthcare solutions company Evolent Health (NYSE:EVH) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 31.3% year on year to $444.3 million. Next quarter’s revenue guidance... 
Via StockStory
Topics Artificial Intelligence
EVH Earnings Drop 31%
Via The Motley Fool
Topics Artificial Intelligence
Evolent Health (EVH) Q2 Earnings Report Preview: What To Look For
Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results this Thursday after the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
3 Small-Cap Stocks We Find Risky
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. 
Via StockStory
Topics Lawsuit Stocks World Trade
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
ELV Q1 Deep Dive: Carelon Expansion and Margin Trends in Focus as Guidance Reaffirmed
Health insurance provider Elevance Health (NYSE:EVH) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 13.4% year on year to $49.78 billion. Its non-GAAP profit of... 
Via StockStory
The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts
 
Via Benzinga
Elevance Health (NYSE:ELV) Beats Q2 Sales Targets
Health insurance provider Elevance Health (NYSE:EVH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 13.4% year on year to $49.78 billion. Its non-GAAP profit of $8.84 per share was... 
Via StockStory
Elevance Health (ELV) Stock Trades Down, Here Is Why
Shares of health insurance provider Elevance Health (NYSE:EVH) fell 11.5% in the afternoon session after the company reported its second-quarter results and cut its full-year profit guidance, citing... 
Via StockStory
Elevance Health (ELV) Reports Earnings Tomorrow: What To Expect
Health insurance provider Elevance Health (NYSE:EVH) will be reporting results this Thursday before the bell. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know
A number of stocks fell in the morning session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
Stocks making big moves this week: Oscar Health, Sunrun, Elevance Health, Tesla, and GMS
Check out the companies making headlines this week: 
Via StockStory
Topics Electric Vehicles
Why Elevance Health (ELV) Shares Are Sliding Today
Shares of health insurance provider Elevance Health (NYSE:EVH) fell 9.9% in the afternoon session after peer, Centene pulled its full-year financial guidance, triggering a sector-wide sell-off. 
Via StockStory
Topics Artificial Intelligence
UBS Views Evolent Health’s Q2 Outlook And Financing Moves As ‘Incrementally Positive’
The company reaffirmed its full-year adjusted core profit guidance and noted that oncology cost trends remained below forecast through the first two-thirds of the quarter. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.